These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 23014094)
1. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094 [TBL] [Abstract][Full Text] [Related]
2. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence. Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858 [TBL] [Abstract][Full Text] [Related]
3. Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases. Kalinauskaite GG; Tinhofer II; Kufeld MM; Kluge AA; Grün AA; Budach VV; Senger CC; Stromberger CC BMC Cancer; 2020 May; 20(1):404. PubMed ID: 32393261 [TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience. Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645 [TBL] [Abstract][Full Text] [Related]
5. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. Andratschke N; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Guckenberger M; Hildebrandt G; Klement RJ; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Habermehl D BMC Cancer; 2018 Mar; 18(1):283. PubMed ID: 29534687 [TBL] [Abstract][Full Text] [Related]
6. Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases. Berkovic P; Gulyban A; Defraene G; Swenen L; Dechambre D; Nguyen PV; Jansen N; Mievis C; Lovinfosse P; Janvary L; Lambrecht M; De Meerleer G BMC Cancer; 2020 May; 20(1):402. PubMed ID: 32384918 [TBL] [Abstract][Full Text] [Related]
7. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach. Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057 [TBL] [Abstract][Full Text] [Related]
8. Stereotactic ablative radiotherapy delivered by image-guided helical tomotherapy for extracranial oligometastases. Sole CV; Lopez Guerra JL; Matute R; Jaen J; Puebla F; Rivin E; Sanchez-Reyes A; Beltran C; Bourgier C; Calvo FA; Marsiglia H Clin Transl Oncol; 2013 Jun; 15(6):484-91. PubMed ID: 23143953 [TBL] [Abstract][Full Text] [Related]
9. Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients. Yamashita H; Onishi H; Matsumoto Y; Murakami N; Matsuo Y; Nomiya T; Nakagawa K; Radiat Oncol; 2014 May; 9():112. PubMed ID: 24886477 [TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy". Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028 [TBL] [Abstract][Full Text] [Related]
11. Stereotactic Body Radiation Therapy (SBRT) Using CyberKnife in Oligometastatic Cancer Patients; Retrospective Evaluation, Single Institution Experience. Alsuhaibani A; Elashwah A; Alkafi A; Constantinescus C; ALzorkany F J Gastrointest Cancer; 2019 Dec; 50(4):879-887. PubMed ID: 30291546 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity. Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292 [TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry. Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848 [TBL] [Abstract][Full Text] [Related]
14. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT? Park HJ; Kim HJ; Won JH; Lee SC; Chang AR Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552 [TBL] [Abstract][Full Text] [Related]
15. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791 [TBL] [Abstract][Full Text] [Related]
16. Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors. Clerici E; Comito T; Franzese C; Di Brina L; Tozzi A; Iftode C; Navarria P; Mancosu P; Reggiori G; Tomatis S; Scorsetti M Strahlenther Onkol; 2020 Apr; 196(4):325-333. PubMed ID: 31605163 [TBL] [Abstract][Full Text] [Related]
17. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study. He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630 [TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer. Hou X; Wang W; Zhang F; Hu K Asia Pac J Clin Oncol; 2019 Oct; 15(5):e175-e180. PubMed ID: 31070018 [TBL] [Abstract][Full Text] [Related]
19. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience. Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558 [TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Kelly P; Balter PA; Rebueno N; Sharp HJ; Liao Z; Komaki R; Chang JY Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1387-93. PubMed ID: 20381271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]